Delivery Order SPE2DB22D2211-SPE2DB23FPGH7

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $3.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,140.42 firm fixed-price delivery order is for Clindamycin Phosphate 1% Lotion, a generic pharmaceutical product. The contract has an ultimate completion date of March 8, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,064 firm-fixed-price delivery order is for the supply of Clindamycin Phosphate 1% Lotion, a topical antimicrobial medication. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,250.04 firm fixed price delivery order is for the supply of 4563412457 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0ZZJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Clindamycin Phosphate 1% Lotion 60mL, a pharmaceutical product, with a ceiling value of $1,284.05. The contract has a firm fixed price and is a delivery order, with a period of performance through February 9, 2024. The contract was awarded on February 8, 2024 and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,346.33 for the delivery of 4559202015 - Clindamycin Phosphate 1% Foam 50GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,457.04 firm fixed-price delivery order is for the supply of Clindamycin Phosphate 1% Lotion, a topical antibiotic medication. The contract has a performance period ending on March 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This federal contract award, valued at $1,534.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Lotion, a pharmaceutical product, to support the healthcare needs of the military and federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $1,121.36 and is for the delivery of clindamycin phosphate 1% lotion, a topical antibiotic medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with the ID SPE2DX15D3504|SPE2DX24F03S2, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,104.12 Firm Fixed Price contract is for the delivery of Clindamycin PH 1% Gel, a pharmaceutical product. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FD8C6, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The award, with a ceiling value of $1,036.56, is for the delivery of Clindamycin Phosphate 1% Lotion, a prescription medication, with an ultimate completion date of September 16, 2024. This appears to be a delivery order contract, with a firm fixed-price pricing type, and is not set aside...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB23FPGH7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,809.36 firm fixed-price delivery order is for the supply of Clindamycin Phosphate 1% Lotion, a pharmaceutical product, with a performance period through September 27, 2023. The award is not designated as a set-aside contract.

Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The company also maintains a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/12/25, 9:49 AM